HIV Transmission Risk Persists During the First 6 Months of Antiretroviral Therapy

Objective: Combination antiretroviral therapy (ART) decreases the risk of sexual HIV transmission by suppressing blood and genital HIV RNA concentrations. However HIV transmission risk may persist prior to achieving complete viral suppression. Design: Prospective cohort study. Methods: Using data from the Partners PrEP Study a prospective study of 4747 heterosexual HIV-serodiscordant couples in Kenya and Uganda we examined multiple markers of HIV transmission risk during the first months after ART initiation: time to viral suppression in blood persistence of HIV RNA in genital specimens sexual risk behavior pregnancy incidence and HIV transmission using survival analysis and GEE logistic regression. Results: The cumulative probabilities of achieving blood viral suppression ( 6 months of ART (0 infections; 167 person-years). Conclusions: Residual HIV transmission risk persists during the first 6-months of ART with incomplete viral suppression in blood and genital compartments. For HIV-serodiscordant couples in which the infected partner starts ART other prevention options are needed such as pre-exposure prophylaxis until viral suppression is achieved. Copyright: 2016 Wolters Kluwer Health Inc.